Анализа корелације ризика између сировог адионектина (АПН), Д-димера (ДД) и нейтрофил-лимфоцитног односа (НЛР) и прогнозе инфекције језичка ујања дијабетичког стопала
Ефекти серума АПН, Д-Д и НЛР на прогнозу инфекције дијабетичког улкуса стопала
Sažetak
Objective: Investigating the connections between diabetic foot ulcer infection patients' prognosis and disease severity, we measured serum adiponectin (APN), D-dimer (D-D), and the neutrophil-to-lymphocyte ratio (NLR).
Methods: A total of 292 patients with diabetic foot ulcer infection admitted to our hospital from February 2024 to February 2025 were selected and divided into mild (n=95), moderate (n=139) and severe (n=58) patients according to the severity of the disease. The levels of serum APN, D-D and the NLR in patients with different severity levels were compared. To analyze serum APN, D-D and the NLR, patients were followed up for one year, and the prognoses of the patients were statistically analyzed.
Results: Comparisons of the serum APN, D-D and NLR levels among patients with different severity, and the serum APN levels in moderate conditions were lower than those in patients with mild conditions (P<0.05). The serum APN of severe patients was 5.35±0.98, and that of moderate patients was 7.64±1.25, which was lower than that of mild patients (9.19±1.73; P<0.05), and the serum APN level of severe patients was lower than that of moderate patients (P<0.05). Comparisons of the serum D-D and NLR levels revealed that the serum D-D and NLR in severe patients were 3.49±0.72 and 2.86±0.58, respectively, and those in moderate patients were 3.02±0.63 and 2.24±0.46, respectively, both of which were greater than those in mild patients, which were 2.43±0.51 and 1.71±0.33 (P<0.05). The levels of serum D-D and the NLR were greater in severe patients than in moderate patients (P<0.05). According to Spearman correlation analysis, the severity of the disease in diabetic foot ulcer infection patients was positively connected with the serum D-D level and NLR (r=0.387, P<0.001; r=0.461, P<0.001) and negatively connected with the serum APN level (r=-0.414, P<0.001). ROC analysis revealed that the optimal cutoff values of the serum APN, D-D and NLR for predicting poor prognosis in patients were 5.73 mg/L, 3.06 mg/L and 2.12, respectively; the sensitivities were 78.57%, 82.14% and 85.71%, respectively; and the specificities were 76.56%, 67.19% and 73.44%, respectively. The areas under the curve (AUCs) were 0.793, 0.784, and 0.818, respectively. The specificity and AUC of the combination of the three methods were 98.44% and 0.918, respectively.
Conclusion: Serum APN and D-D levels and the NLR in patients with diabetic foot ulcer infection are related to disease severity. The serum APN, D-D and NLR can be used as sensitive indicators for predicting poor patient prognosis.
Reference
2.Xue E, Shi Q, Guo S, Zhang X, Liu C, Qian B, Guo X, Hu N, Jiang F, Tao J, Wang W. Preexisting diabetes, serum calcium and D-dimer levels as predictable risk factors for pancreatic necrosis of patients with acute pancreatitis: a retrospective study. Expert Rev Gastroenterol Hepatol. 2022 Sep;16(9):913-921.
3.Zhang Y, Li T, Yue CY, Liu Y. Associations of serum D-dimer and glycosylated hemoglobin levels with third-trimester fetal growth restriction in gestational diabetes mellitus. World J Diabetes. 2024 May 15;15(5):914-922.
4.Cheng L, Fu Q, Zhou L, Fan Y, Liu F, Fan Y, Zhang X, Lin W, Wu X. D-dimer as a predictor of cardiovascular outcomes in patients with diabetes mellitus. BMC Cardiovasc Disord. 2022 Mar 4;22(1):82.
5.Zhang LS, Yu P, Yao F, Lu ZQ, Li XM, Chen H. Insulin autoantibodies, D-dimer and microalbuminuria: A cross-sectional, case‒control study of type 2 diabetes. World J Diabetes. 2025 Feb 15;16(2):101501.
6.Hashim Ibrahim Elbashir I, Kamal Ali Mohamed H, Adam Essa ME, Seri A. Comparison between D-dimer levels in diabetic and nondiabetic positive COVID-19 adult patients: A hospital-based study. Endocrinol Diabetes Metab. 2022 Jul;5(4):e349.
7.Zhou BY, Zhang Q, Hu YC, Wang L, Zhang JX, Cong HL, Wang L. Association of D-dimer with long-term prognosis in type 2 diabetes mellitus patients with acute coronary syndrome. Nutr Metab Cardiovasc Dis. 2022 Aug;32(8):1955-1962.
8.Zhuang L, Yu C, Xu F, Zhao LH, Wang XH, Wang CH, Ning LY, Zhang XL, Zhang DM, Wang XQ, Su JB. Increased plasma D-dimer levels may be a promising indicator for diabetic peripheral neuropathy in type 2 diabetes. Front Endocrinol (Lausanne). 2022 Aug 23;13:930271.
9.Yu Y, Zhu C, Lin Y, Qian Q, Shen X, Zou W, Wang M, Gong J, Chen M, Liu L, Yu R, Shen Q, Shao L, Zhu B. Plasma D-dimer levels are associated with disease progression in diabetic nephropathy: a two-center cohort study. Ren Fail. 2023;45(2):2285868. d
10.Li Q, Lin X, Bo X, Chen S, Zhao D, Liu J, Fan Q. Association of D-dimer to albumin ratio with adverse cardiovascular outcomes in ischemic heart failure patients with diabetes mellitus: a retrospective cohort study. BMJ Open. 2024 Jan 22;14(1):e078013.
11.Li B, Liu X, Gao M, Ma L, Yao W, Zhao Y. Predictive Value of D-Dimer for In-Hospital Mortality in Non-Diabetic Patients with Non-ST-segment Elevation Myocardial Infarction. Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241276820.
12.Wu L, Zheng Y, Liu J, Luo R, Wu D, Xu P, Wu D, Li X. Comprehensive evaluation of the efficacy and safety of LPV/r drugs in the treatment of SARS and MERS to provide potential treatment options for COVID-19. Aging (Albany NY). 2021 Apr 20;13(8):10833-10852.
13.Li X, Wang L, Liu M, Zhou H, Xu H. Association between neutrophil-to-lymphocyte ratio and diabetic kidney disease in type 2 diabetes mellitus patients: a cross-sectional study. Front Endocrinol (Lausanne). 2024 Jan 4;14:1285509.
14.Xie T, Tang WW. Could emergency admission plasma D-dimer level predict first pass effect of stent retriever thrombectomy in acute ischemic stroke? Acta Radiol. 2024 Apr;65(4):367-373.
15.Wu L, Zhong Y, Wu D, Xu P, Ruan X, Yan J, Liu J, Li X. Immunomodulatory Factor TIM3 of Cytolytic Active Genes Affected the Survival and Prognosis of Lung Adenocarcinoma Patients by Multi-Omics Analysis. Biomedicines. 2022 Sep 10;10(9):2248.
16.Milczak A, Winiarczyk D, Winiarczyk S, Bochyńska D, Adaszek Ł, Winiarczyk M, Lechowski R. Procoagulant and anticoagulant plasma indicators in diabetic dogs showing increased antithrombin III levels in canine diabetes mellitus. BMC Vet Res. 2022 Mar 19;18(1):108.
17.Wu L, Liu Q, Ruan X, Luan X, Zhong Y, Liu J, Yan J, Li X. Multiple Omics Analysis of the Role of RBM10 Gene Instability in Immune Regulation and Drug Sensitivity in Patients with Lung Adenocarcinoma (LUAD). Biomedicines. 2023 Jun 29;11(7):1861.
18.Lemon NM, Taylor LK, Rech MA, Nguyen Q, Matthews GJ, Lew G, Lovett S. Utility of D-dimer in predicting pulmonary embolism in patients with COVID-19 presenting to the emergency department. J Am Coll Emerg Physicians Open. 2024 Jul 17;5(4):e13237.
19.Chen HL, Wu C, Cao L, Wang R, Zhang TY, He Z. The association between the neutrophil-to-lymphocyte ratio and type 2 diabetes mellitus: a cross-sectional study. BMC Endocr Disord. 2024 Jul 9;24(1):107.
20.Chen G, Che L, Lai M, Wei T, Chen C, Zhu P, Ran J. Association of neutrophil-lymphocyte ratio with all-cause and cardiovascular mortality in US adults with diabetes and prediabetes: a prospective cohort study. BMC Endocr Disord. 2024 May 10;24(1):64.
21.Gupta A, Singh K, Fatima S, Ambreen S, Zimmermann S, Younis R, Krishnan S, Rana R, Gadi I, Schwab C, Biemann R, Shahzad K, Rani V, Ali S, Mertens PR, Kohli S, Isermann B. Neutrophil Extracellular Traps Promote NLRP3 Inflammasome Activation and Glomerular Endothelial Dysfunction in Diabetic Kidney Disease. Nutrients. 2022 Jul 20;14(14):2965. doi: 10.3390/nu14142965. Erratum in: Nutrients. 2023 May 23;15(11):2429.
22.Wu L, Zheng Y, Ruan X, Wu D, Xu P, Liu J, Wu D, Li X. Long-chain noncoding ribonucleic acids affect the survival and prognosis of patients with esophageal adenocarcinoma through the autophagy pathway: construction of a prognostic model. Anticancer Drugs. 2022 Jan 1;33(1):e590-e603.
23.Chen X, Li A, Ma Q. Neutrophil-lymphocyte ratio and systemic immune-inflammation index as predictors of cardiovascular risk and mortality in prediabetes and diabetes: a population-based study. Inflammopharmacology. 2024 Oct;32(5):3213-3227.
24.Fang Y, Wang B, Pang B, Zhou Z, Xing Y, Pang P, Zheng D, Zhang G, Yang B. Exploring the relations of NLR, hsCRP and MCP-1 with type 2 diabetic kidney disease: a cross-sectional study. Sci Rep. 2024 Feb 8;14(1):3211.
25.Li Y, Li G, Li J, Luo Z, Lin Y, Lan N, Zhang X. Correlation of diabetes and adverse outcomes in hospitalized COVID-19 patients admitted to a tertiary hospital in China during a small-scale COVID-19 outbreak. PeerJ. 2025 Jan 27;13:e18865.
26.Satheesan A, Kumar J, Leela KV, Murugesan R, Chaithanya V, Angelin M. Review on the role of nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome pathway in diabetes: mechanistic insights and therapeutic implications. Inflammopharmacology. 2024 Oct;32(5):2753-2779.
27.Mousavi S, Safari A, Nateghian H, Ghojazadeh M, Nikniaz L. Comparing the detection rate of postpartum diabetes in early and 4-12 week postpartum screening tests in women with gestational diabetes mellitus: A systematic review and meta-analysis. Taiwan J Obstet Gynecol. 2023 May;62(3):396-401.
28.Tang Y, Li L, Li J. Association between neutrophil-to-lymphocyte ratio and diabetic retinopathy in patients with type 2 diabetes: a cohort study. Front Endocrinol (Lausanne). 2024 Jul 11;15:1396161.
Sva prava zadržana (c) 2025 Guodong Guo, Xiaohui Zhang, Peng Fang, Kangkanng Li, Chaoyang Wang, Gang Liu, Huijuan Ma
Ovaj rad je pod Creative Commons Autorstvo 4.0 međunarodnom licencom.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.